Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services

SOL #: 36C25026Q0104Award Notice

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
250-NETWORK CONTRACT OFFICE 10 (36C250)
DAYTON, OH, 45428, United States

Place of Performance

Cleveland, OH

NAICS

Medical Laboratories (621511)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Dec 30, 2025

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

The Department of Veterans Affairs, Network Contracting Office 10, made an award for a one (1) year firm fixed price (FFP) contract with Adaptive Biotechnologies Corporation, 1165 Eastlake Ave. E, Seattle WA, 98109 to provide Clono-Seq Assay testing services for the Louis Stokes VA Medical Center, Pathology & Laboratory Services (PALMS), 10701 East BLVD., Cleveland, OH 44106.

The point of contact is Thomas Bellamy, Contracting Officer, Network Contracting Office 10 - Thomas.Bellamy@va.gov.

People

Points of Contact

Thomas BellamyPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Award Notice
Posted: Dec 30, 2025
Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services | GovScope